Retinitis Pigmentosa is a genetic form of vision loss. While rare, its impact on day-to-day living can be devastating, especially as symptoms usually start in early childhood. Now, an important advance in gene-based treatment is offering new hope to many patients.
About the author
Monica Matys is a Communications Advisor at Sunnybrook.
Have a question about this post? Get in touch.